Dow Down 1.29% Nasdaq Down 3.25%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM
3.65 Down 0.15(3.95%) Feb 5, 3:59PM EST
Prev Close:3.80
Open:3.86
Bid:3.10 x 300
Ask:12.82 x 600
1y Target Est:26.25
Beta:0.408752
Next Earnings Date:N/A
Day's Range:3.57 - 3.91
52wk Range:3.05 - 10.85
Volume:12,665
Avg Vol (3m):69,121
Market Cap:33.04M
P/E (ttm):N/A
EPS (ttm):-2.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABIODown 3.95%33.04M
AZNDown 1.44%75.92B
GSKDown 0.54%98.64B
ILIU 0.00%12.10M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.75
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatm... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback